The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInsights - Sarilumab, a new Rheumatoid Arthritis (RA) drug from Sanofi (SNY) and Regeneron (REGN), showed positive results in its first Phase 3 clinical trial. If approved, … Continue Reading
Read nowInsights - Forest Laboratories Inc. (FRX) and Gedeon Richter Plc. announced that the U.S. Federal Drug Administration (FDA) issued a complete response letter regarding the New Drug … Continue Reading
Read nowResearch - It seems QLT Inc. may be on the block after a press release on Wednesday evening indicated the company has engaged Credit Suisse as a … Continue Reading
Read nowResearch - Note: This article was sent to PropThink Premium members during the afternoon of November 20, 2013. Also see our follow-up commentary here. In morning trading, … Continue Reading
PremiumInsights - Amgen’s (AMGN) PCSK9 inhibitor evolucumab (AMG145), when added to standard treatments, helped 86% of patients get their LDL cholesterol levels to a target of 100 … Continue Reading
Read now- It appears that Vertex Pharmaceutical’s (VRTX) decision to scale back its support for its Hepatitis-C treatment, Incivek, was well reasoned in the face of continued … Continue Reading
PremiumResearch - We’ve watched AcelRx Pharmaceuticals (ACRX) for some time in 2013 as the stock has pulled back meaningfully, falling from a high of over $13 to … Continue Reading
Premium
